Completed PHASE2 INTERVENTIONAL 2-arm NCT01929135

Short-term Effect of 2% Atorvastatin Dentifrice in Periodontal Status.

Short-term Effect of 2% Atorvastatin Dentifrice as an Adjunct to Periodontal Therapy: A Randomized Double-blind Clinical Trial.

Sponsor: Corporación de Fomento de la Producción, Chile

Conditions Chronic Periodontitis

Interventions Medicated 2% atorvastatin dentifrice Non-medicated dentifrice

Updated 7 times since 2017 Last updated: Jul 25, 2014 Started: May 31, 2013 Primary completion: Jan 31, 2014 Completion: Jun 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Chronic Periodontitis and is currently completed. Corporación de Fomento de la Producción, Chile leads this study, which shows 7 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Oct 2021 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Oct 2021 [monthly]

Completed PHASE2
Jan 2019 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 2 earlier versions

Jun 2018 — Jan 2019 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

May 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Corporación de Fomento de la Producción, Chile
Universidad de los Andes, Chile

Data source: Universidad de los Andes, Chile

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Santiago, Chile